Abstract:The peripheral nervous system has an intrinsic ability to regenerate after injury. However, this process is slow, incomplete, and often accompanied by disturbing motor and sensory consequences. Sciatic nerve injury (SNI), which is the most common model for studying peripheral nerve injury, is characterized by damage to both motor and sensory fibers. The main goal of this study is to examine the feasibility of administration of human muscle progenitor cells (hMPCs) overexpressing neurotrophic factor (NTF) genes, known to protect peripheral neurons and enhance axon regeneration and functional recovery, to ameliorate motoric and sensory deficits in SNI mouse model. To this end, hMPCs were isolated from a human muscle biopsy, and manipulated to ectopically express brain-derived neurotrophic factor (BDNF), glial-cell-line-derived neurotrophic factor (GDNF), vascular endothelial growth factor (VEGF), and insulin-like growth factor (IGF-1). These hMPC-NTF were transplanted into the gastrocnemius muscle of mice after SNI, and motor and sensory functions of the mice were assessed using the CatWalk XT system and the hot plate test. ELISA analysis showed that genetically manipulated hMPC-NTF express significant amounts of BDNF, GDNF, VEGF, or IGF-1. Transplantation of 3 × 106 hMPC-NTF was shown to improve motor function and gait pattern in mice following SNI surgery, as indicated by the CatWalk XT system 7 days post-surgery. Moreover, using the hot-plate test, performed 6 days after surgery, the treated mice showed less sensory deficits, indicating a palliative effect of the treatment. ELISA analysis following transplantation demonstrated increased NTF expression levels in the gastrocnemius muscle of the treated mice, reinforcing the hypothesis that the observed positive effect was due to the transplantation of the genetically manipulated hMPC-NTF. These results show that genetically modified hMPC can alleviate both motoric and sensory deficits of SNI. The use of hMPC-NTF demonstrates the feasibility of a treatment paradigm, which may lead to rapid, high-quality healing of damaged peripheral nerves due to administration of hMPC. Our approach suggests a possible clinical application for the treatment of peripheral nerve injury.

Targeted Expression of IGF‐1 Transgene to Skeletal Muscle Accelerates Muscle and Motor Neuron Regeneration

PI3 Kinase Regulation of Neural Regeneration and Muscle Hypertrophy after Spinal Cord Injury

Local expression of IGF‐1 accelerates muscle regeneration by rapidly modulating inflammatory cytokines and chemokines

Implantation of Muscle Satellite Cells Overexpressing Myogenin Improves Denervated Muscle Atrophy in Rats

A Sensitized IGF1 Treatment Restores Corticospinal Axon-Dependent Functions

IGF-1 Potentiates Sensory Innervation Signalling by Modulating the Mitochondrial Fission/fusion Balance

Insulin-Like Growth Factor-1 Enhances Motoneuron Survival and Inhibits Neuroinflammation after Spinal Cord Transection in Zebrafish

Postischemic IGF-1 Gene Transfer Promotes Neurovascular Regeneration after Experimental Stroke

Human Muscle Progenitor Cells Overexpressing Neurotrophic Factors Improve Neuronal Regeneration in a Sciatic Nerve Injury Mouse Model

Angiogenic Gene-Modified Myoblasts Promote Vascularization During Repair of Skeletal Muscle Defects

Therapeutic Potential of Growth Hormone in Peripheral Nerve Injury: Enhancing Schwann Cell Proliferation and Migration Through IGF‐1R‐AKT and ERK Signaling Pathways

Modified Insulin-Like Growth Factor 1 Containing Collagen-Binding Domain for Nerve Regeneration

Non-viral induction of transient cell reprogramming in skeletal muscle to enhance tissue regeneration

Construction of Plasmid DNA Expressing Two Isoforms of Insulin-Like Growth Factor-1 and Its Effects on Skeletal Muscle Injury Models

Delivery of AAV-IGF-1 to the CNS extends survival in ALS mice through modification of aberrant glial cell activity

GSK3β inhibitor promotes myelination and mitigates muscle atrophy after peripheral nerve injury

Inhibitory Effect of IGF-1 Gene on Motoneurons Apoptosis in Anterior Horn after Acute Spinal Cord Injury in Adult Rats

The Effect of Myoblast Carrying Human IGF-1 Injection on the Endogenous mIGF-1 mRNA Expression in Mice Skeletal Muscle following Injury

Intrathecal delivery of recombinant AAV1 encoding hepatocyte growth factor improves motor functions and protects neuromuscular system in the nerve crush and SOD1-G93A transgenic mouse models

Accelerating axonal growth promotes motor recovery after peripheral nerve injury in mice

Survival and hIGF-1 Expression of Transplanted Myoblast Carrying hIGF-1 in vivo